Allogene Therapeutics to Report Second Quarter Financial Results on August 4, 2021
SOUTH SAN FRANCISCO, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that it will report second quarter 2021 financial results on Wednesday, August 4, 2021, after the close of the market. The announcement will be followed by a live audio webcast and conference call at 2:00 PM Pacific Time/5:00 PM Eastern Time.
About Allogene Therapeutics
Cautionary Note on Forward-Looking Statements
AlloCAR T™ is a trademark of Allogene Therapeutics, Inc.
Allogene Media/Investor Contact:
Asset Management â€“ Keeping Remote Devices Connected
Ease Interoperability in Smart Cities - How Standards Can Prevent Vendor-lock-in
7 Elements of a Successful Cannabis VAR